Lista de obras - Miguel Unda - Dominio Público Uruguay

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.

artículo científico publicado en 2013

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

artículo científico publicado en 2018

Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples

artículo científico publicado en 2016

Effect of Mode of Administration on I&ndash;PSS Scores in a Large BPH Patient Population ⬇️

artículo científico publicado el 1 de octubre de 2001

Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer.

artículo científico

Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options.

artículo científico publicado en 2013

Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms.

artículo científico publicado en 2001

Influence of the true number of Bacillus Calmette-Guérin instillations on the prognosis of non-muscle invasive bladder tumors

artículo científico publicado en 2014

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha

artículo científico publicado en 1997

Is the bench getting closer to the bedside in the war on cancer? A quick look at prostate cancer.

artículo científico publicado en 2012

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.

artículo científico publicado en 2015

Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN

artículo científico publicado en 2015

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

artículo científico publicado en 2009

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

artículo científico publicado en 2007

Prostate cancer in Spain: from guidelines to clinical practice ⬇️

artículo científico publicado el 11 de enero de 2011

Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a ra

artículo científico publicado en 2014

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables ⬇️

artículo científico publicado el 25 de mayo de 2011

The impact of peptidase activity on clear cell renal cell carcinoma survival

artículo científico publicado en 2012

Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.

artículo científico publicado en 2016

Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.

artículo científico publicado en 2009

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

artículo científico publicado en 2013

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

artículo científico publicado en 2017

Lista de obras de Miguel Unda

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples

Effect of Mode of Administration on I&amp;ndash;PSS Scores in a Large BPH Patient Population ⬇️

Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer.

Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options.

Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms.

Influence of the true number of Bacillus Calmette-Guérin instillations on the prognosis of non-muscle invasive bladder tumors

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha

Is the bench getting closer to the bedside in the war on cancer? A quick look at prostate cancer.

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.

Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Prostate cancer in Spain: from guidelines to clinical practice ⬇️

Sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a ra

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables ⬇️

The impact of peptidase activity on clear cell renal cell carcinoma survival

Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.

Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications.

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Effect of Mode of Administration on I–PSS Scores in a Large BPH Patient Population ⬇️